• Je něco špatně v tomto záznamu ?

Postprandial oxidative stress and gastrointestinal hormones: is there a link

H. Malinska, H. Kahleova, O. Topolcan, J. Vrzalova, O. Oliyarnyk, L. Kazdova, L. Belinova, M. Hill, T. Pelikanova,

. 2014 ; 9 (8) : e103565.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15023113

BACKGROUND: Abnormal postprandial elevation of plasma glucose and lipids plays an important role in the pathogenesis of diabetes and strongly predicts cardiovascular mortality. In patients suffering from type 2 diabetes (T2D) postprandial state is associated with oxidative stress, cardiovascular risk and, probably, with impairment of both secretion and the effect of gastrointestinal peptides. Evaluating postprandial changes of gastrointestinal hormones together with changes in oxidative stress markers may help to understand the mechanisms behind the postprandial state in diabetes as well as suggest new preventive and therapeutical strategies. METHODS: A standard meal test has been used for monitoring the postprandial concentrations of gastrointestinal hormones and oxidative stress markers in patients with T2D (n = 50) compared to healthy controls (n = 50). Blood samples were drawn 0, 30, 60, 120 and 180 minutes after the standard meal. RESULTS: Both basal and postprandial plasma concentrations of glucose and insulin proved to be significantly higher in patients with T2D, whereas plasma concentrations of ghrelin showed significantly lower values during the whole meal test. In comparison with healthy controls, both basal and postprandial concentrations of almost all other gastrointestinal hormones and lipoperoxidation were significantly increased while ascorbic acid, reduced glutathione and superoxide dismutase activity were decreased in patients with T2D. A positive relationship was found between changes in GIP and those of glucose and immunoreactive insulin in diabetic patients (p<0.001 and p<0.001, respectively) and between changes in PYY and those of glucose (p<0.01). There was a positive correlation between changes in GIP and PYY and changes in ascorbic acid in patients with T2D (p<0.05 and p<0.001, respectively). CONCLUSION/INTERPRETATION: Apart from a positive relationship of postprandial changes in GIP and PYY with changes in ascorbic acid, there was no direct link observed between gastrointestinal hormones and oxidative stress markers in diabetic patients. TRIAL REGISTRATION: ClinicalTrials.gov NCT01572402.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15023113
003      
CZ-PrNML
005      
20150709122741.0
007      
ta
008      
150709s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0103565 $2 doi
035    __
$a (PubMed)25141237
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Malinska, Hana $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
245    10
$a Postprandial oxidative stress and gastrointestinal hormones: is there a link / $c H. Malinska, H. Kahleova, O. Topolcan, J. Vrzalova, O. Oliyarnyk, L. Kazdova, L. Belinova, M. Hill, T. Pelikanova,
520    9_
$a BACKGROUND: Abnormal postprandial elevation of plasma glucose and lipids plays an important role in the pathogenesis of diabetes and strongly predicts cardiovascular mortality. In patients suffering from type 2 diabetes (T2D) postprandial state is associated with oxidative stress, cardiovascular risk and, probably, with impairment of both secretion and the effect of gastrointestinal peptides. Evaluating postprandial changes of gastrointestinal hormones together with changes in oxidative stress markers may help to understand the mechanisms behind the postprandial state in diabetes as well as suggest new preventive and therapeutical strategies. METHODS: A standard meal test has been used for monitoring the postprandial concentrations of gastrointestinal hormones and oxidative stress markers in patients with T2D (n = 50) compared to healthy controls (n = 50). Blood samples were drawn 0, 30, 60, 120 and 180 minutes after the standard meal. RESULTS: Both basal and postprandial plasma concentrations of glucose and insulin proved to be significantly higher in patients with T2D, whereas plasma concentrations of ghrelin showed significantly lower values during the whole meal test. In comparison with healthy controls, both basal and postprandial concentrations of almost all other gastrointestinal hormones and lipoperoxidation were significantly increased while ascorbic acid, reduced glutathione and superoxide dismutase activity were decreased in patients with T2D. A positive relationship was found between changes in GIP and those of glucose and immunoreactive insulin in diabetic patients (p<0.001 and p<0.001, respectively) and between changes in PYY and those of glucose (p<0.01). There was a positive correlation between changes in GIP and PYY and changes in ascorbic acid in patients with T2D (p<0.05 and p<0.001, respectively). CONCLUSION/INTERPRETATION: Apart from a positive relationship of postprandial changes in GIP and PYY with changes in ascorbic acid, there was no direct link observed between gastrointestinal hormones and oxidative stress markers in diabetic patients. TRIAL REGISTRATION: ClinicalTrials.gov NCT01572402.
650    _2
$a krevní glukóza $x analýza $7 D001786
650    _2
$a diabetes mellitus 2. typu $x krev $7 D003924
650    _2
$a kyseliny mastné neesterifikované $x krev $7 D005230
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a gastrointestinální hormony $x krev $7 D005768
650    _2
$a lidé $7 D006801
650    _2
$a inzulin $x krev $7 D007328
650    _2
$a lipidy $x krev $7 D008055
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a oxidační stres $x fyziologie $7 D018384
650    _2
$a postprandiální období $x fyziologie $7 D019518
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kahleova, Hana $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Topolcan, Ondrej $u Faculty Hospital Pilsen, Pilsen, Czech Republic.
700    1_
$a Vrzalova, Jindra $u Faculty Hospital Pilsen, Pilsen, Czech Republic.
700    1_
$a Oliyarnyk, Olena $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Kazdova, Ludmila $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Belinova, Lenka $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Charles University, 1st Faculty of Medicine, Prague, Czech Republic.
700    1_
$a Hill, Martin $u Institute of Endocrinology, Prague, Czech Republic.
700    1_
$a Pelikanova, Terezie $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 9, č. 8 (2014), s. e103565
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25141237 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150709 $b ABA008
991    __
$a 20150709122800 $b ABA008
999    __
$a ok $b bmc $g 1083451 $s 906106
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 9 $c 8 $d e103565 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20150709

Najít záznam

Citační ukazatele

Možnosti archivace